Rep. Waxman Challenges FDA Contact With Rx Companies On DTC Guides
Executive Summary
Rep. Henry Waxman (D-Calif.) is asking FDA to defend its communications with pharmaceutical companies relating to the development of direct-to-consumer advertising guidances
You may also be interested in...
FDA Releases DTC Guidances; “Not The Last Word” On Ads, McClellan Says
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
FDA Releases DTC Guidances; “Not The Last Word” On Ads, McClellan Says
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
FDA Goes Global: Trade Talks Suggest Drug Prices Are Part Of Mission
FDA's involvement in trade negotiations with Australia is the latest sign that the agency's mission is evolving under Commissioner McClellan toward the once-taboo topic of pharmaceutical prices